Observational studyEuropean journal of clinical investigation2026

Long-term effectiveness and safety outcomes in adults with Fabry disease treated with agalsidase alfa: 20 years of data from the Fabry Outcome Survey.

Derralynn A Hughes et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.